Puma Ducati Drugs Bring Hope To Cancer Puma Ferra

par5zmi4gy · Wysłany: Śro 11:33, 02 Mar 2011

here is our easy-to-make recipe for green tea, but this one tastes so good you’ll never guess how good it is for you! A great, healthy thirst-quencher for hot summer days. Technology. We live in a grand time of technological development. Computers, the Internet, cell phones, digital cameras and DVDs. But the human body has not 'kept up' with technology.
Illegal drugs and alcohol are addicting. Records show that the younger you are when you experiment with illegal drugs or alcohol you are more prone to become an addict in the future.
Class of Drugs Brings Hope to Cancer Patients
This is an exciting time in cancer research. Recent information on angiogenesis -- the growth of new blood vessels -- is providing researchers opportunities to find new ways to slow or stop a tumor's growth by cutting off the blood supply it needs.
Angiogenesis performs a critical role in the development of cancer. To grow, solid tumors need oxygen and nutrients provided by new blood vessels. Once a vascular network has been generated, cancer cells can also invade the rest of the body, a process called metastasis. Currently, researchers believe that more than 90 percent of all cancer cases are angiogenesis-dependent. The good news is that a novel class of drugs, which acts as angiogenesis inhibitors, shows great potential in fighting more than 20 different diseases, including many types of cancer.
These "anti-angiogenesis" drugs being developed and tested block the formation of new blood vessels, starving cancerous cells and stopping tumor growth. One drug being tested, Neovastat [link widoczny dla zalogowanych], was discovered in 1994 and is derived from cartilage tissue. Neovastat is the only angiogenesis inhibitor being developed in the biotechnology and pharmaceutical universe that has four mechanisms of action to combat blood vessel growth. Furthermore, Neovastat is taken orally, making it convenient for patients who need long-term treatment, and it has shown minimal side effects in clinical trials. This means that unlike standard chemotherapy, Neovastat is not likely to interfere with a patient's immune system, or cause adverse gastrointestinal symptoms or hair loss.
In addition [link widoczny dla zalogowanych], because most cancer cells are genetically unstable and more prone to mutations, resistance is a major problem with many chemotherapy agents. But since anti-angiogenesis drugs target normal endothelial cells that are not genetically unstable [link widoczny dla zalogowanych], drug resistance is less likely to develop and has not been a problem so far in clinical trials.
Have you ever washed greasy dishes without hot water or dish soap? The dishes don't get clean, do they? When toxic metals and chemical food additives get inside your body, it takes a strong "cleanser" to scrub your body clean from the inside out.
Hence, it is important to create an alternative that will promptly help the body to gain back its detoxification capacity and fight back imminent diseases.
Do I believe in detox? Well, most of it is plain simple commonsense - proper diet, judicious supplementation, adequate rest, exercise, stress-relieving techniques.
Metal toxicity can cause health issues that range from headaches and aching bones to memory loss and discoloration of the skin and nails.
People with addiction work hard to resolve them, and with the support of family members and friends they are able to recover on their own. However in most cases, people they usually cannot stop drinking or using drugs by willpower alone. A lot of them require outside help, mostly from Alcohol Rehab or Drug Rehab.
Another hope is that angiogenesis inhibitors can be used in combination with therapies that directly target tumor cells. Because anti-angiogenic drugs and chemotherapy are aimed at different cellular targets, it is possible that the combination will prove even more effective than either therapy is as a stand-alone. Currently, Neovastat is the subject of three clinical trials, targeting three forms